CPHD Insider Trading Activity and SEC Form 4 Filings
CPHD insider trading summary
No open-market insider purchases or sales of Cepheid (CPHD) have been reported on SEC Form 4 in the past 12 months.
Latest CPHD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 17, 2016 | Scott A. Campbell | Corporate VP & CRO | Sell | $10K (287 @ $36.16) |
| Aug 5, 2016 | Scott A. Campbell | Corporate VP & CRO | Sell | $6K (157 @ $37.57) |
| Aug 4, 2016 | Scott A. Campbell | Corporate VP & CRO | Sell | $2K (58 @ $36.19) |
| Aug 2, 2016 | Scott A. Campbell | Corporate VP & CRO | Sell | $25K (688 @ $36.75) |
| May 3, 2016 | Scott A. Campbell | Corporate VP & CRO | Sell | $57K (2,058 @ $27.90) |
| May 2, 2016 | Peter V. Farrell | EVP, Worldwide Commercial Ops | Sell | $11K (390 @ $28.90) |
| Apr 28, 2016 | Peter V. Farrell | EVP, Worldwide Commercial Ops | Sell | $14K (390 @ $36.30) |
| Apr 25, 2016 | John L Bishop | Chairman of the Board and CEO | Sell | $3.9M (110,000 @ $35.50) |
| Mar 10, 2016 | Peter V. Farrell | EVP, Worldwide Commercial Ops | Sell | $13K (393 @ $33.01) |
| Feb 29, 2016 | Robert J Easton | Director | Sell | $389K (12,500 @ $31.13) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.